[ad_1] KRAKÓW, Poland, Sept. 24, 2024 /PRNewswire/ — Selvita S.A. (WSE: SLV), one of the leading preclinical contract research organizations in Europe, has published its financial results for Q2 2024, earnings estimates for Q3 204 and […]
[ad_1] KRAKÓW, Poland, Sept. 24, 2024 /PRNewswire/ — Selvita S.A. (WSE: SLV), one of the leading preclinical contract research organizations in Europe, has published its financial results for Q2 2024, earnings estimates for Q3 204 and […]